Molecular Imaging of HER2 Expression in HER2-positive Breast Cancer Using 99mTc-ADAPT6 vs 99mTc-DARPinG3
Clinical trial NCT05376644 · COMPLETED
Trial details
- NCT number
- NCT05376644
- Sponsor
- Tomsk National Research Medical Center of the Russian Academy of Sciences
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2022-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.